Abstract:Tegeleqi Bu, Li Fang Wang, Yi Qing Yin Department of Anesthesiology, China-Japan Friendship Hospital, Beijing, People's Republic of China Correspondence: Yi Qing Yin Department of Anesthesiology, China-Japan Friendship Hospital, Ying Hua East Road No. 2, Chaoyang District, Beijing, People's Republic of China Tel +86 135 2126 2509 Email yyq518@sina.com Recently, the therapeutic potential of immune-modulation during the progression of chronic obstructive pulmonary disease (COPD) has been attracting increasing interest. However, chronic inflammatory response has been over-simplified in descriptions of the mechanism of COPD progression. As a form of first-line airway defense, epithelial cells exhibit phenotypic alteration, and participate in epithelial layer disorganization, mucus hypersecretion, and extracellular matrix deposition. Dendritic cells (DCs) exhibit attenuated antigen-presenting capacity in patients with advanced COPD. Immature DCs migrate into small airways, where they promote a pro-inflammatory microenvironment and bacterial colonization. In response to damage-associated molecular patterns (DAMPs) in lung tissue affected by COPD, neutrophils are excessively recruited and activated, where they promote a proteolytic microenvironment and fibrotic repair in small airways. Macrophages exhibit decreased phagocytosis in the large airways, while they demonstrate high pro-inflammatory potential in the small airways, and mediate alveolar destruction and chronic airway inflammation. Natural killer T (NKT) cells, eosinophils, and mast cells also play supplementary roles in COPD progression; however, their cellular activities are not yet entirely clear. Overall, during COPD progression, "exhausted" innate immune responses can be observed in the large airways. On the other hand, the innate immune response is enhanced in the small airways. Approaches that inhibit the inflammatory cascade, chemotaxis, or the activation of inflammatory cells could possibly delay the progression of airway remodeling in COPD, and may thus have potential clinical significance. Keywords: innate immune cell, airway remodeling, lung immunity, immune tolerance, chronic obstructive pulmonary disease

The innate immune function of airway epithelial cells in inflammatory lung disease

Airway remodelling in asthma and the epithelium: on the edge of a new era

The Origin and Role of Innate Lymphoid Cells in the Lung

Innate Immunity of the Lung: From Basic Mechanisms to Translational Medicine

Cytokine targets in airway inflammation

A cellular census of healthy lung and asthmatic airway wall identifies novel cell states in health and disease

Airway Epithelial Orchestration of Innate Immune Function in Response to Virus Infection. A Focus on Asthma.

The Epithelial-Immune Crosstalk in Pulmonary Fibrosis

Innate lymphoid cells: critical regulators of allergic inflammation and tissue repair in the lung

How Do Innate Immune Cells Contribute to Airway Remodeling in COPD Progression?

Airway Epithelial Dysfunction in the Development of Acute Lung Injury and Acute Respiratory Distress Syndrome.

Role of Airway Epithelial Cells in Development of Chronic Obstructive Pulmonary Disease

Neutrophil Infiltration and Function in the Pathogenesis of Inflammatory Airspace Disease

Role of Airway Epithelial Barrier Dysfunction in Bronchial Asthma

Role of Airway Epithelial Cells in Development of Asthma and Allergic Rhinitis

The epithelium in idiopathic pulmonary fibrosis: breaking the barrier

Epithelial alarmins: a new target to treat chronic respiratory diseases

Innate players in Th2 and non-Th2 asthma: emerging roles for the epithelial cell, mast cell, and monocyte/macrophage network

Airway hyperresponsiveness in asthma: the role of the epithelium

The Role of Innate Immunity in Pulmonary Infections

Epithelial-neuronal-immune cell interactions: implications for immunity, inflammation, and tissue homeostasis at mucosal sites